Stock-based compensation (Tables)
|
12 Months Ended |
Mar. 30, 2024 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Restricted Stock Awards Granted |
The following table summarizes the Company's restricted stock award grants during fiscal 2023, fiscal 2022, and fiscal 2021. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Grant Date | | Total Number of Awards Granted | | Grant Date Fair Value | | Number of Time-Based Awards Granted | | Time-Based Vesting Period | | Number of Performance- Based Awards Granted | | Performance- Based Vesting Period | | Number of Performance- Based Awards that Met Performance Condition | June 1, 2021 | | 335,719 | | $ | 13.22 | | | 98,343 | | 3 | years | 237,376 | (1) | 3 | years | 237,376 | September 1, 2021 | | 90,040 | | $ | 11.55 | | | 90,040 | | 1 | year | — | | N/A | | N/A | March 29, 2022 | | 6,408 | | $ | 8.67 | | | 6,408 | | 1 | year | — | | N/A | | N/A | June 1, 2022 | | 994,681 | | $ | 7.56 | | | 234,062 | | 3 | years | 760,619 | (2) | 3 | years | 0 | August 31, 2022 | | 153,392 | | $ | 6.78 | | | 153,392 | | 1 | year | — | | N/A | | N/A | June 1, 2023 | | 1,586,596 | | $ | 2.48 | | | 394,729 | | 3 | years | 1,191,867 | (3) | 3 | years | 0 | August 30, 2023 | | 146,340 | | $ | 2.34 | | | 146,340 | | 1 | year | — | | N/A | | N/A | March 26, 2024 | | 20,848 | | $ | 1.08 | | | 20,848 | | 1 | year | — | | N/A | | N/A |
___________________________ (1)These performance-based restricted stock awards vest based on achievement of fiscal 2021 performance targets and are also subject to time-based vesting requirements. (2)These performance-based restricted stock awards vest based on achievement of fiscal 2022 performance targets and are also subject to time-based vesting requirements. (3)These performance-based restricted stock awards vest based on achievement of fiscal 2023 performance targets and are also subject to time-based vesting requirements.
|
Schedule of Restricted Stock Awards Activity |
The following table summarizes the Company’s restricted stock awards activity during fiscal 2022 and fiscal 2023: | | | | | | | | | | | | | | | | | Restricted Stock Awards | | Weighted Average Grant Date Fair Value | Nonvested at April 2, 2022 | | 990,773 | | $ | 7.89 | | Granted | | 1,148,073 | | 7.45 | | Vested | | (412,988) | | 7.84 | | Forfeited | | (877,301) | | 7.50 | | Withheld related to net settlement | | (86,482) | | 6.22 | | Nonvested at April 1, 2023 | | 762,075 | | $ | 7.87 | | Granted | | 1,753,777 | | 2.17 | | Vested | | (426,249) | | 7.23 | | Forfeited | | (1,351,489) | | 2.45 | | Withheld related to net settlement | | (57,984) | | 6.41 | | Nonvested at March 30, 2024 | | 680,130 | | $ | 4.39 | |
|
Schedule of Stock Option Activity |
The following table summarizes the Company’s stock option activity during fiscal 2023, fiscal 2022, and fiscal 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fiscal Year | | | 2023 | | 2022 | | 2021 | | | Shares | | Weighted- average exercise price (per share) | | Weighted- average contractual term remaining (years) | | Aggregate intrinsic value (thousands) | | Shares | | Weighted- average exercise price (per share) | | Weighted- average contractual term remaining (years) | | Aggregate intrinsic value (thousands) | | Shares | | Weighted- average exercise price (per share) | | Weighted- average contractual term remaining (years) | | Aggregate intrinsic value (thousands) | | Beginning balance | 1,713,070 | | $ | 15.74 | | | | | | | 1,966,465 | | $ | 15.49 | | | | | | | 2,259,041 | | $ | 15.07 | | | | | | | Granted | — | | $ | — | | | | | | | — | | $ | — | | | | | | | — | | $ | — | | | | | | | Exercised | — | | $ | — | | | | | | | (73,594) | | $ | 4.62 | | | | | | | (125,777) | | $ | 4.50 | | | | | | | Forfeited | — | | $ | — | | | | | | | — | | $ | — | | | | | | | — | | $ | — | | | | | | | Expired | (1,330,988) | | $ | 18.00 | | | | | | | (179,801) | | $ | 17.53 | | | | | | | (166,799) | | $ | 18.09 | | | | | | | Ending balance | 382,082 | | $ | 7.86 | | | 2.51 | | $ | — | | | 1,713,070 | | $ | 15.74 | | | 1.24 | | $ | — | | | 1,966,465 | | $ | 15.49 | | | 2.21 | | $ | 1,287,521 | | | Vested and exercisable at end of year | 382,082 | | $ | 7.86 | | | 2.51 | | $ | — | | | 1,713,070 | | $ | 15.74 | | | 1.24 | | $ | — | | | 1,966,465 | | $ | 15.49 | | | 2.21 | | $ | 1,287,521 | | |
|